ClinicalTrials.gg
CompletedNCT05202496Updated Jan 21, 2022

Effect of Systemic Administration of Vitamin D on the Rate of Orthodontic Tooth Movement - A Randomized Control Trial

An interventional study of Calcitriol 0.25Mcg Cap and orthodontic treatment in Angle Class I, sponsored by Postgraduate Institute of Dental Sciences Rohtak. Completed at 1 site in India. Open to participants aged 19 Years to 25 Years. Per ClinicalTrials.gov, last updated 2022-01-21.

Sponsored by Postgraduate Institute of Dental Sciences Rohtak · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Nov 2019, registered Jan 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
19 Years to 25 Years
Sex
All
01

Study summary

This study is to evaluate the effect of vitamin D on the rate of tooth movement by measuring and comparing the extraction space closure during retraction in experimental (vitamin D supplemented) and control groups with a sample size of 24 and having serum vitamin D level (30-40 ng/ml). All subjects undergo orthodontic levelling and alignment after premolar extractions followed by vitamin D supplementation in the experimental group. The rate of canine retraction will be measured in both the groups and CBCT taken in the interval of 6 months before and after intervention to measure root changes

Read the detailed description

Aims and Objectives: To evaluate the effect of vitamin D on the rate of tooth movement by measuring and comparing the extraction space closure during retraction in experimental (vitamin D supplemented) and control groups. Secondary objective: To compare root resorption in experimental and control group. Setting: Department of Orthodontics and Dentofacial Orthopaedics, PGIDS, Rohtak.

Study Design: Prospective, double blind, randomized clinical study Time frame: Duration of study is one year Population/participant: Inclusion criteria:- Patients with age between 19-25 years with malocclusion requiring bilateral extraction of maxillary 1st premolars in good general health and healthy periodontium.

Exclusion Criteria:- Presence of any systemic/bone/metabolic/hormonal diseases, long-term drug history, pregnant or lactating women, smoking habit, root resorption orany chronic disorders Sample size: A sample size of 10 per group for the present study was calculated to detect a clinical difference of 0.89 with a pooled standard deviation of 0.53 (effect size 1.67) at 95% power and alpha significance level at 0.05.

To compensate for 20% dropouts the final sample size was calculated to be 11 per group (i.e) total sample size will be 24.

Method of study: Patients who fulfill the selection criteria will be selected for the study. After taking the pretreatment records and recording the pretreatment vitamin D levels the patients will be sent for extraction of 1st premolars. Treatment will be initiated by bonding 0.022"slot MBT straight wire appliance. Retraction will be done on 0.019"x 0.025" SS wires using closed coil NiTi springs. Patients of study group will be instructed to take adequate dose of vitamin D3 during phase of space closure. Serum vitamin D levels will be checked at 4th,8th, 12th and 16th weeks and rate of canine retraction will be measured at these time intervals. Root resorption will be measured from CBCT at the end of 6 months Outcome Measures: The outcome variables will be the rate of retraction measured in millimeters. Changes in root length will be measured and compared between the two groups Statistical Analysis: Data will be checked for normality. If it is in normal distribution, intra group comparison will be done by student's t-test between two time points and inter group comparison will be done by using Independent T test between two groups. If it is in non-normal distribution, intra group comparison will be done by Wilcoxon signed rank test and inter group comparison will be done by Mann-Whitney U test.

02

Conditions studied

  • Angle Class I
03

In context

Malocclusion, Angle Class I

35 studies on the registry are indexed under Malocclusion, Angle Class I; 10 are open to participants now.

This study's enrollment of 24 is below the median of 32 across 31 interventional studies indexed under Malocclusion, Angle Class I.

Browse Malocclusion, Angle Class I studies →

Lead sponsor

Postgraduate Institute of Dental Sciences Rohtak is the lead sponsor of 213 studies on the registry; 72 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patient in the age group of 19-25 years .
  2. Good general health status.
  3. Healthy periodontium
  4. Absence of root resorption.
  5. Absence of any chronic disorders
  6. No history of orthodontic treatment.

Exclusion criteria

Exclusion Criteria:

  1. Presence of any signs and symptoms of gingival and periodontal diseases.
  2. Any Systemic/Bone/metabolic/hormonal disease illness known to affect the outcome of orthodontic therapy or requiring administration of vitamin D
  3. Any kind of prolonged drug administration (chronic drug intake)
  4. Pregnant or lactating women.
  5. Smoking habit.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Experimental: oral vitamin D supplementation during orthodontic treatment

    The biological methods include using various chemicals like parathyroid hormone, thyroid hormone, prostaglandins, corticosteroids, relaxin and vitamin D. Due to its important role in bone remodeling, vitamin D is hypothesized to play an important role in accelerating orthodontic tooth movement. experimental group subjects with serum vitamin D levels in the range of 30-40 ng/ml are enrolled

    Drug: Calcitriol 0.25Mcg Cap · Procedure: orthodontic treatment

  • Active comparator
    control : Orthodontic treatment with no intervention

    control group subjects with serum vitamin D levels in the range of (30-40 ng/ml) are enrolled

    Procedure: orthodontic treatment

Interventions

  • After orthodontic levelling and alignment, experimental group subjects are administered one capsule of calcitriol 0.25 mcg on a daily basis during the study period. Also, serum vitamin D levels are monitored at monthly intervals and rate of canine retraction is measured at monthly intervals

    Also known as: Rocaltrol

  • Procedureorthodontic treatment

    experimental group subjects undergo orthodontic treatment after extraction of premolars

06

What researchers measure

Primary outcomes

  1. Measurement of rate of canine retraction

    Distal movement of maxillary canine is measured in mm with the help of electric digital caliper after beginning of maxillary canine retraction

    Time frame: 4th week

  2. Measurement of rate of canine retraction

    Distal movement of maxillary canine is measured in mm with the help of electric digital caliper after beginning of maxillary canine retraction

    Time frame: 8th week

  3. Measurement of rate of canine retraction

    Distal movement of maxillary canine is measured in mm with the help of electric digital caliper after beginning of maxillary canine retraction

    Time frame: 12th week

  4. Measurement of rate of canine retraction

    Distal movement of maxillary canine is measured in mm with the help of electric digital caliper after beginning of maxillary canine retraction

    Time frame: 16th week

Secondary outcomes

  1. Measurement of Root resorption

    Root resorption is measured in relation to canine with the help of CBCT taken before and after intervention

    Time frame: 6 months

07

Study locations

1 site
  • Pgids,Rohtak
    Rohtak, Haryana 124001, India
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2019 to primary completion in Apr 2021, 17 months.

Of 23 interventional studies with no phase under Malocclusion, Angle Class I, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 24. This study's 17 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 9, 2022
First posted
Jan 21, 2022
StartActual
Nov 20, 2019
Primary completionActual
Apr 30, 2021
CompletionActual
Dec 31, 2021
Last update
Jan 21, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05202496
Responsible party
Sponsor
First posted
Jan 21, 2022
Start date
Nov 20, 2019
Primary completion
Apr 30, 2021
Completion
Dec 31, 2021
Last update
Jan 21, 2022

Study contacts

Rekha Sharma, MDS
study chair · PGIDS,ROHTAK

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Calcitriol

Start the discussion